# A Study to Assess AXN-2510 Treatment in Adult Patients With Advanced Solid Tumors

> **NCT07159828** · PHASE1 · TERMINATED · sponsor: **Axion Bio, Inc** · enrollment: 3 (actual)

## Conditions studied

- Solid Tumor, Adult

## Interventions

- **BIOLOGICAL:** AXN-2510

## Key facts

- **NCT ID:** NCT07159828
- **Lead sponsor:** Axion Bio, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2025-09-15
- **Primary completion:** 2026-04-16
- **Final completion:** 2026-04-16
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** The study was terminated early due to discontinuation of development of the investigational program.
- **Last updated:** 2026-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07159828

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07159828, "A Study to Assess AXN-2510 Treatment in Adult Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07159828. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*